156 related articles for article (PubMed ID: 37970615)
41. [Observation of the therapeutic and characteristic effects of terlipressin on refractory cirrhotic ascites].
Xing F; Li S; Zhang JJ; Sun CY; Huang JR; Gao ZL; Zhu TT; Zhao Q; Zhang H; Liu CH
Zhonghua Gan Zang Bing Za Zhi; 2019 Dec; 27(12):982-988. PubMed ID: 31941260
[No Abstract] [Full Text] [Related]
42. Lymphatic interventions for isolated, iatrogenic chylous ascites: A multi-institution experience.
Majdalany BS; Khayat M; Downing T; Killoran TP; El-Haddad G; Khaja MS; Saad WA
Eur J Radiol; 2018 Dec; 109():41-47. PubMed ID: 30527310
[TBL] [Abstract][Full Text] [Related]
43. Successful treatment of chylous ascites by superselective embolization of the inflowing lymphatic vessels using a steerable microcatheter: a case study.
Hamaguchi S; Michigami Y; Inoue M; Tsukamoto K; Wada S; Ogawa Y
Radiol Case Rep; 2022 Sep; 17(9):3205-3208. PubMed ID: 35801127
[TBL] [Abstract][Full Text] [Related]
44. Use of orlistat (xenical) to treat chylous ascites.
Chen J; Lin RK; Hassanein T
J Clin Gastroenterol; 2005 Oct; 39(9):831-3. PubMed ID: 16145348
[TBL] [Abstract][Full Text] [Related]
45. The effectiveness of the treatment of octreotide on chylous ascites after liver cirrhosis.
Zhou DX; Zhou HB; Wang Q; Zou SS; Wang H; Hu HP
Dig Dis Sci; 2009 Aug; 54(8):1783-8. PubMed ID: 19051030
[TBL] [Abstract][Full Text] [Related]
46. Continuous peritoneal drainage of large-volume ascites.
Van Thiel DH; Moore CM; Garcia M; George M; Nadir A
Dig Dis Sci; 2011 Sep; 56(9):2723-7. PubMed ID: 21735084
[TBL] [Abstract][Full Text] [Related]
47. Transjugular intrahepatic portosystemic shunt for chylous ascites in a patient with recurrent cirrhosis following liver transplantation.
Salsamendi JT; Gortes FJ; Mohan PP; Fan J; Narayanan G
Radiol Case Rep; 2017 Mar; 12(1):84-86. PubMed ID: 28228886
[TBL] [Abstract][Full Text] [Related]
48. Zonulin Family Peptide Levels in Ascites and Serum in Patients with Liver Cirrhosis: A Preliminary Study.
Pietrukaniec M; Migacz M; Żak-Gołąb A; Olszanecka-Glinianowicz M; Chudek J; Duława J; Holecki M
Dis Markers; 2019; 2019():2804091. PubMed ID: 31781297
[TBL] [Abstract][Full Text] [Related]
49. Microcirculatory changes in the liver of patients with refractory ascites and their relationship with diabetes and alcohol.
Elkrief L; Buyse S; Panhard X; Baudry C; Gault N; Moreau R; Rautou PE; Belghiti J; Durand F; Bedossa P; Paradis V; Valla D
Eur J Gastroenterol Hepatol; 2021 Dec; 33(1S Suppl 1):e145-e152. PubMed ID: 33208687
[TBL] [Abstract][Full Text] [Related]
50. Chylous ascites after living related liver transplantation treated with somatostatin analog and parenteral nutrition.
Baran M; Cakir M; Yüksekkaya HA; Arikan C; Aydin U; Aydogdu S; Kilic M
Transplant Proc; 2008; 40(1):320-1. PubMed ID: 18261617
[TBL] [Abstract][Full Text] [Related]
51. Chylous ascites should suggest constrictive pericarditis even in a patient with cirrhosis.
Williams AT; Schneider RP
J Clin Gastroenterol; 1990 Oct; 12(5):581-4. PubMed ID: 2230003
[TBL] [Abstract][Full Text] [Related]
52. Treatment for ascites in adults with decompensated liver cirrhosis: a network meta-analysis.
Benmassaoud A; Freeman SC; Roccarina D; Plaz Torres MC; Sutton AJ; Cooper NJ; Iogna Prat L; Cowlin M; Milne EJ; Hawkins N; Davidson BR; Pavlov CS; Thorburn D; Tsochatzis E; Gurusamy KS
Cochrane Database Syst Rev; 2020 Jan; 1(1):CD013123. PubMed ID: 31978257
[TBL] [Abstract][Full Text] [Related]
53. Clinical Profile, Response to Therapy, and Outcome of Children with Primary Intestinal Lymphangiectasia.
Prasad D; Srivastava A; Tambe A; Yachha SK; Sarma MS; Poddar U
Dig Dis; 2019; 37(6):458-466. PubMed ID: 31030202
[TBL] [Abstract][Full Text] [Related]
54. Primary intestinal lymphangiectasia (Waldmann's disease).
Vignes S; Bellanger J
Orphanet J Rare Dis; 2008 Feb; 3():5. PubMed ID: 18294365
[TBL] [Abstract][Full Text] [Related]
55. Chylous ascites as a manifestation of thyrotoxic cardiomyopathy in a patient with untreated Graves' disease.
Hsieh MH; Chen CC; Wang TY; Chang CT
Thyroid; 2010 Jun; 20(6):653-5. PubMed ID: 20470210
[TBL] [Abstract][Full Text] [Related]
56. Chylous ascites: Case report of a rare presentation of blunt abdominal trauma.
Fernandes V; Queirós J; Soares C
Int J Surg Case Rep; 2020; 77():799-802. PubMed ID: 33395899
[TBL] [Abstract][Full Text] [Related]
57. Management of refractory ascites by using a peritoneal dialysis system with extracorporeal ultrafiltration by hemodialysis dialyzer.
Itami N; Kimura J; Ohira S; Tsuji Y; Katsuki Y
Perit Dial Int; 2003 Dec; 23 Suppl 2():S170-4. PubMed ID: 17986541
[TBL] [Abstract][Full Text] [Related]
58. Management of refractory chylous ascites with peritoneovenous shunts.
Huang Y; Gloviczki P; Duncan AA; Fleming MD; Driscoll DJ; Kalra M; Oderich GS; Bower TC
J Vasc Surg Venous Lymphat Disord; 2017 Jul; 5(4):538-546. PubMed ID: 28623993
[TBL] [Abstract][Full Text] [Related]
59. Pathological Investigation of Acquired Lymphangiectasia Accompanied by Lower Limb Lymphedema: Lymphocyte Infiltration in the Dermis and Epidermis.
Hara H; Mihara M; Anan T; Fukumoto T; Narushima M; Iida T; Koshima I
Lymphat Res Biol; 2016 Sep; 14(3):172-80. PubMed ID: 27599121
[TBL] [Abstract][Full Text] [Related]
60. Non-selective beta-blockers impair global circulatory homeostasis and renal function in cirrhotic patients with refractory ascites.
Téllez L; Ibáñez-Samaniego L; Pérez Del Villar C; Yotti R; Martínez J; Carrión L; Rodríguez de Santiago E; Rivera M; González-Mansilla A; Pastor Ó; Bermejo J; Bañares R; Albillos A
J Hepatol; 2020 Dec; 73(6):1404-1414. PubMed ID: 32446716
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
